ERBB2 and neoplasm: No significant differences in tumor onset, incidence and burden were observed when MMTV-neu/IL-1R8−/−mice were transplanted with IL-1R8+/+ bone-marrow cells, supporting an important role for IL-1R8 expression by non-hematopoietic/tumor cells during breast tumorigenesis (Supplementary Figure 2).